|1.||Jeon, Jun Ho: 1 article (02/2011)|
|2.||Baik, Jung Eun: 1 article (02/2011)|
|3.||Ahn, Ki Bum: 1 article (02/2011)|
|4.||Yun, Cheol-Heui: 1 article (02/2011)|
|5.||Park, Ok-Jin: 1 article (02/2011)|
|6.||Han, Seung Hyun: 1 article (02/2011)|
|7.||Im, Jintaek: 1 article (02/2011)|
|8.||Kim, Sun Kyung: 1 article (02/2011)|
|9.||Sekimoto, Masashi: 1 article (01/2006)|
|10.||Degawa, Masakuni: 1 article (01/2006)|
02/01/2011 - "In conclusion, our results suggest that Trp-P-1 is immunosuppressive by inhibiting the functionality of DCs that play an essential role in the appropriate induction of anti-cancer immune responses."
11/01/1987 - "In the mice given Trp-P-1, the incidences of these tumors were as follows: liver tumors in 45% of the males; malignant lymphoma in 13% of the males and in 24% of the females. "
11/01/1987 - "Statistical analysis revealed that the incidences of the liver tumor in the mice given Trp-P-1 or Trp-P-2 and those of lymphoma in the mice given Trp-P-1 were significantly higher than those of the controls. "
04/01/1994 - "Since related heterocyclic amines induce tumors and other lesions in the rodent vascular system, the results raise the possibility that Trp-P-1 and other food mutagens may play a role in cardiovascular disease."
01/01/1981 - "MC and DMBA, which are known to induce cancer of respiratory organs in experimented animals, and DAB, aflatoxin B1 and Trp-P-1, which are strong carcinogens in the liver, did not induce UDS within 2 h. "
04/15/1991 - "A carcinogenic, food-derived heterocyclic amine, 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole (Trp-P-1) was found to reduce the enzymatic activity of tyrosine hydroxylase in clonal rat pheochromocytoma PC12h cells, by its supplement to the culture medium. "
01/01/1994 - "After culture of a dopamine cell model, clonal pheochromocytoma PC12h cells, with Trp-P-1 activity of tyrosine hydroxylase was decreased by reduction of its affinity to the biopterin cofactor. "
05/08/1989 - "Uptake of heterocyclic amines, Trp-P-1 and Trp-P-2, into clonal rat pheochromocytoma PC12h cells by dopamine uptake system."
|4.||Hepatocellular Carcinoma (Hepatoma)
09/01/1985 - "When Trp-P-1 was given to male and female F344 rats at concentrations of 0.015% and 0.02%, respectively, in the diet, it induced hepatocellular carcinomas in high incidence within a year. "
08/01/1986 - "In rats, hepatocellular carcinomas were induced by Trp-P-1, Glu-P-1, Glu-P-2, and IQ. "
|5.||Chromosome Aberrations (Chromosome Abnormalities)
09/01/1992 - "The number of chromosome aberrations induced by UV and MMC were increased by post-treatment with Trp-P-1 and Trp-P-2, in both the presence and the absence of S9 mix. "
09/01/1992 - "Trp-P-1, Trp-P-2, A alpha C, MeA alpha C and Glu-P-1 were weak clastogens by themselves, but at much higher concentrations than those at which they increased the induction of chromosome aberrations in cells pretreated with UV or MMC. "
11/01/1991 - "Intraperitoneal injections of Trp-P-1, Glu-P-1, MeIQx, IQ and nitro-IQ resulted in chromosome aberrations in up to 16% of the metaphase cells and SCEs at up to 0.9 per chromosome, while injections of Trp-P-2 and Glu-P-2 produced SCEs at up to 0.7 and 1.1 per chromosome, respectively. "
|1.||Peptide Hydrolases (Proteases)
|3.||2- amino- 6- methyldipyrido(1,2- a- 3',2'- d)imidazole
|4.||Aflatoxin B1 (Aflatoxin B)
|5.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)